2013 annual financial data
NovoCure 2013 Operating margin
NovoCure 2013 operating margin with verified reported values.
Direct answer
Operating margin was -622.25%.
Operating income was -64,459,000 USD and net income was -77,370,000 USD.
Operating cash flow was -52,717,000 USD.
Get free NovoCure email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,359,000 USD
- Operating income
- -64,459,000 USD
- Net income
- -77,370,000 USD
- Operating cash flow
- -52,717,000 USD